Remove Bioavailability Remove Bioequivalency Remove Production Remove Regulation
article thumbnail

Can a CRL Be Final Agency Action: One Step Closer to Finding Out

FDA Law Blog

Circuit, their client Nostrum Laboratories sought judicial review after FDA agreed to allow a certain type of study to establish bioequivalence for generic theophylline, Nostrum conducted those studies, and then FDA issued a CRL asking for new, time-consuming, expensive studies of a different sort.